Antivirals Flashcards
Which blood-borne viruses have no vaccine?
- human immunodeficiency virus (HIV)
- hepatitis C virus (HCV)
What viruses have no vaccine that are not blood-borne?
- Herpesviruses (Herpes simplex virus type-1, HSV-2, Epstein-Barr virus, cytomegalovirus)
- Enteroviruses (echoviruses, coxsackieviruses)
- Rhinoviruses (common cold)
- Paramyxoviruses (resp syncitial virus - RSV)
Why are viral infections hard to treat?
They rely on host cell machinery for their own replication
Thus, therapy should target some viral process and not interfere with cellular function (selectivity)
Ideally, an antiviral should NOT be:
- Toxic
- Mutagenic
- Teratogenic
- Carcinogenic
- Allergenic
What are the 5 viral targets?
- Attachment and entry to host cell
- Uncoating
- Genome replication
- Expression and processing of viral genes and proteins
- Virus assembly
Can different viruses use the same host cell receptor?
Yes
How do viruses enter host cells?
Viruses have multiple receptor binding sites on their surface, also called virus attachment proteins (VAPs). These interact with host cell receptors. Sometimes they also interact with a host cell co-receptor.
What are host cell receptors?
They are cellular proteins which can interact with specific viral proteins.
What type of viral attachment protein do enveloped viruses have?
Glycoprotein
What type of viral attachment protein do on-enveloped viruses have?
A spike or capsid protein
What are the two processes by which viruses can enter host cells?
- Endocytosis
2. Fusion
What is the process of fusion? E.g. HIV
Glycoprotein 120 binds to CD4 Conformational change CCR5 is recruited Glycoprotein 41 binds to the cell surface Viral membrane fuses to cell membrane
What is the process of endocytosis?
Virus binds to receptor
Coated pit forms
Virus is taken up in an endosome
Virus uncoats and DNA/RNA enters the nucleus
What are some agents that can be used to prevent attachment and entry?
- Agents which mimic the virus attachment protein
- Agents which mimic the host cell receptor
- Agents which inhibit fusion
How do agents which mimic the virus attachment protein work?
They act by blocking the host cell receptor, however, by doing this it can interfere with cellular functions and may be toxic
How do agents that mimic the host cell receptor work?
These are typically antibodies or proteins.
In the case of HIV they can recombinant soluble CD4 receptor peptides. However, whilst they worked well in cell culture they underperformed in clinical trials. High doses were required, which cost more and they weren’t very stable.
How do agents that inhibit fusion work?
They target conformation changes that are critical to membrane fusion.
In the case of HIV T20 (Enfuvertide) was developed which inhibited HIV fusion by binding to gp41, preventing the hinging effect and the virus cannot get close enough to the membrane to fuse.
What is T20 (Enfuvertide)?
It is an agent that inhibits the fusion of HIV to the cell membrane by binding to gp41, preventing the hinging effect and preventing the virus from getting close to the membrane to fuse.
What are the steps involved in uncoating?
- Release of the viral nucleic acid
- by change in pH
- by proteolytic digestion
What are the 3 drugs that inhibit uncoating?
- Pleconaril (picovir)
- Amantidine
- Rimantidine
What is Pleconaril (picovir)?
It is a broad spectrum anti-viral against picornaviruses, which include enteroviruses and rhinoviruses.
It acts by preventing uncoating.
What is the mode of action of pleconaril (picovir)?
- Binds to a cavity or pocket on the virus capsid
- Increases the stability of the capsid
- Protects the capsid from proteolytic digestion
- Prevents uncoating
Is pleconaril (picovir) approved for use by the FDA?
The FDA declined licensing in 2003 as it only had a modest reduction in duration and severity of symptoms.
What is amantidine and rimantidine?
They are agents that are active against influenza A, and target the viral matrix protein 2 (M2)